<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><title>SEC FORM 
            3</title><style type="text/css">
              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; 
              		font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}
              body {background: white;}
      </style></head><body>SEC Form 3 
   <table width="100%" border="0" cellspacing="0" cellpadding="4"><tr><td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td><td rowspan="1" width="60%" valign="middle" align="center"><span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span></td><td rowspan="1" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box"><tr><td class="FormTextC">OMB APPROVAL</td></tr><tr><td><table width="100%" border="0" summary="OMB Interior Box"><tr><td class="SmallFormText" colspan="3">OMB Number:</td><td class="SmallFormTextR">3235-0104</td></tr><tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr><tr><td class="SmallFormText" colspan="3">hours per response:</td><td class="SmallFormTextR">0.5</td></tr></table></td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><tr><td rowspan="3" width="30%" valign="top"><span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0002127312">Giesler Gary Scott</a></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(Last)</td><td width="33%" class="MedSmallFormText">(First)</td><td width="33%" class="MedSmallFormText">(Middle)</td></tr></table><table border="0" width="100%"><tr><td><span class="FormData">C/O GROVE COLLABORATIVE HOLDINGS, INC.</span></td></tr><tr><td><span class="FormData">1301 SANSOME STREET</span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr><td width="33%"><span class="FormData">SAN FRANCISCO</span></td><td width="33%"><span class="FormData">
				CALIFORNIA
			</span></td><td width="33%"><span class="FormData">94111</span></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(City)</td><td width="33%" class="MedSmallFormText">(State)</td><td width="33%" class="MedSmallFormText">(Zip)</td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" colspen="3"><span class="FormData">UNITED STATES</span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Country)</span></td><td rowspan="3" width="15%" valign="top"><span class="MedSmallFormText">2. Date of Event Requiring Statement
         (Month/Day/Year)</span><br><span class="FormData">03/12/2026</span></td><td valign="top" colspan="2"><span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
      </span><br><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001841761">Grove Collaborative Holdings, Inc.</a>
     [ <span class="FormData">GROV</span> ]
   </td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">3a. Foreign Trading Symbol
		 <br></span></td><td valign="top"><span class="MedSmallFormText">5. If Amendment, Date of Original Filed
         (Month/Day/Year)</span><br></td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
      </span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%"><tr><td width="15%" align="center"></td><td width="35%" class="MedSmallFormText">Director</td><td width="15%" align="center"></td><td width="35%" class="MedSmallFormText">10% Owner</td></tr><tr><td align="center"><span class="FormData">X</span></td><td class="MedSmallFormText">Officer (give title below)</td><td align="center"></td><td class="MedSmallFormText">Other (specify below)</td></tr><tr><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue">Chief Legal Officer, Secretary</td><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue"></td></tr></table></td><td valign="top"><span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
      </span><table border="0" width="100%"><tr><td width="15%" align="center"><span class="FormData">X</span></td><td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td></tr><tr><td width="15%" align="center"></td><td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr><tr><th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr. 
      4)
   </th><th width="19%" valign="top" align="left" class="MedSmallFormText">2. 
      Amount of Securities Beneficially Owned (Instr. 
      4)
   </th><th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr></thead><tbody><tr><td align="left"><span class="FormData">Class A Common Stock</span></td><td align="center"><span class="FormData">143,845</span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr></tbody></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC"><b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b></th></tr><tr><th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr. 
      4)
   </th><th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date 
      (Month/Day/Year)</th><th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr. 
      4)
   </th><th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
   </th><th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr><tr><th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th><th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th><th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th><th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th></tr></thead><tbody><tr><td align="left"><span class="FormData">Restricted Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(1)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">Class A Common Stock</span></td><td align="center"><span class="FormData">38,200</span></td><td align="center"><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr><tr><td align="left"><span class="FormData">Restricted Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(4)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">Class A Common Stock</span></td><td align="center"><span class="FormData">17,500</span></td><td align="center"><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr><tr><td align="left"><span class="FormData">Restricted Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(5)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">Class A Common Stock</span></td><td align="center"><span class="FormData">55,633</span></td><td align="center"><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr><tr><td align="left"><span class="FormData">Restricted Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(6)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">Class A Common Stock</span></td><td align="center"><span class="FormData">41,667</span></td><td align="center"><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr><tr><td align="left"><span class="FormData">Restricted Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(7)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">Class A Common Stock</span></td><td align="center"><span class="FormData">137,931</span></td><td align="center"><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr></tbody></table><table border="0" width="100%"><tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr><tr><td class="FootnoteData">1. 40% of the shares subject to the Award vested on February 15, 2025, with 10% of the shares subject to the Award vesting thereafter on the Company's Standard Quarterly Vesting Dates (February 15th, May 15th, August 15th and November 15th of each year; provided, that if such date occurs on a weekend or federal holiday, vesting shall occur on the next business day) beginning with May 15, 2025.</td></tr><tr><td class="FootnoteData">2. The RSUs have no expiration date.</td></tr><tr><td class="FootnoteData">3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of class A Common Stock</td></tr><tr><td class="FootnoteData">4. 1/12th of the shares subject to the Award shall vest on each of the Company's Standard Quarterly Vesting Dates (February 15th, May 15th, August 15th and November 15th of each year; provided, that if such date occurs on a weekend or federal holiday, vesting shall occur on the next business day) beginning February 15, 2025.</td></tr><tr><td class="FootnoteData">5. 1/12th of the shares subject to the Award shall vest on each of the Company's Standard Quarterly Vesting Dates (February 15th, May 15th, August 15th and November 15th of each year; provided, that if such date occurs on a weekend or federal holiday, vesting shall occur on the next business day) beginning May 15, 2025.</td></tr><tr><td class="FootnoteData">6. 1/12th of the shares subject to the Award shall vest on each of the Company's Standard Quarterly Vesting Dates (February 15th, May 15th, August 15th and November 15th of each year; provided, that if such date occurs on a weekend or federal holiday, vesting shall occur on the next business day) beginning November 15, 2025.</td></tr><tr><td class="FootnoteData">7. 1/12th of the shares subject to the Award shall vest on each of the Company's Standard Quarterly Vesting Dates (February 15th, May 15th, August 15th and November 15th of each year; provided, that if such date occurs on a weekend or federal holiday, vesting shall occur on the next business day) beginning May 15, 2026.</td></tr></table><table width="100%" border="0"><tr><td width="60%"></td><td width="20%"><u><span class="FormData">/s/ Barbara R. Wallace, attorney-in-fact for Scott Giesler</span></u></td><td width="20%"><u><span class="FormData">04/08/2026</span></u></td></tr><tr><td></td><td class="MedSmallFormText">** Signature of Reporting Person</td><td class="MedSmallFormText">Date</td></tr><tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr><tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person, 
                  <i>see</i>

                  Instruction 
                  5

                  (b)(v).</td></tr><tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 
                  <i>See</i>

                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr><tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, 
                  <i>see</i>

                  Instruction 6 for procedure.</td></tr><tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr><tr><td colspan="3" class="MedSmallFormText"><b>* Form 3: SEC 1473 (03-26)</b></td></tr></table></body></html>
